Cite
HARVARD Citation
Assouline, S. et al. (2020). IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 61 (7), pp. 1653-1659. [Online].